---
figid: PMC3684083__nihms459788f2
figlink: /pmc/articles/PMC3684083/figure/F2/
number: F2
caption: 'Under physiological conditions, activation of TGFβR complex I and II following
  TGFβ binding results in G1 cell cycle arrest (through the inhibitory activity of
  P21WAF1/CIP1) (central panel). These effects are mediated via the serine threonine
  kinase of the receptor complex, SMAD2,3,4 activation (through phosphorylation) and
  nuclear targeting of these transcription factors. BMP receptors are also associated
  with activation of the SMAD cascade. In NENs (and other tumors e.g., glioblastomas),
  nuclear targeting of SMAD is inhibited and cross-activation of growth-stimulatory
  pathways occur including the RAS/RAF/MAPK signaling pathway and the PI3K/AKT/mTOR
  pathways. Under these circumstances, TGFβ switches to a pro-proliferative role.
  No preclinical or clinical studies have been conducted using TGFβRI inhibitors in
  NENs, while other studies have demonstrated the utility of targeting the mTOR pathway.
  Solid lines: good evidence for pathway activation; dotted lines: incomplete evidence.'
pmcid: PMC3684083
papertitle: 'EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical
  Therapeutic Targets.'
reftext: M. Kidd, et al. Neuroendocrinology. ;97(1):35-44.
pmc_ranked_result_index: '25212'
pathway_score: 0.9578574
filename: nihms459788f2.jpg
figtitle: 'EGFR/TGFA and TGFB/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical
  Therapeutic Targets'
year: ''
organisms:
- Mus musculus
- Rattus norvegicus
- clinical samples
- Homo sapiens
ndex: 13f6f454-dee5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3684083__nihms459788f2.html
  '@type': Dataset
  description: 'Under physiological conditions, activation of TGFβR complex I and
    II following TGFβ binding results in G1 cell cycle arrest (through the inhibitory
    activity of P21WAF1/CIP1) (central panel). These effects are mediated via the
    serine threonine kinase of the receptor complex, SMAD2,3,4 activation (through
    phosphorylation) and nuclear targeting of these transcription factors. BMP receptors
    are also associated with activation of the SMAD cascade. In NENs (and other tumors
    e.g., glioblastomas), nuclear targeting of SMAD is inhibited and cross-activation
    of growth-stimulatory pathways occur including the RAS/RAF/MAPK signaling pathway
    and the PI3K/AKT/mTOR pathways. Under these circumstances, TGFβ switches to a
    pro-proliferative role. No preclinical or clinical studies have been conducted
    using TGFβRI inhibitors in NENs, while other studies have demonstrated the utility
    of targeting the mTOR pathway. Solid lines: good evidence for pathway activation;
    dotted lines: incomplete evidence.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - PIK3CB
  - PIK3CG
  - BMP2
  - HRAS
  - AKT2
  - PIK3CD
  - AKT3
  - AKT1
  - PIK3R3
  - PIK3R6
  - MAP2K2
  - MTOR
  - PIK3R4
  - PIK3CA
  - SMAD4
  - TGFB1
  - TGFB2
  - MAPK1
  - MAPK3
  - TGFB3
  - BRAF
  - SMAD3
  - THRA
  - PIK3R5
  - SMAD2
  - THRB
  - NRAS
  - MAP2K1
  - TGFBR1
  - BEZ235
  - Cancer
  - Cardiomyopathy
  - Lung cancer
genes:
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: (BMP2)
  symbol: BMP2
  source: hgnc_symbol
  hgnc_symbol: BMP2
  entrez: '650'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: SMAD4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: SMAD3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: SER/THR
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRA
  entrez: '7067'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: SMAD2
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: SER/THR
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRB
  entrez: '7068'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: TGFBRI
  symbol: TGFBR1
  source: hgnc_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
chemicals:
- word: BEZ235
  source: MESH
  identifier: C531198
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC3684083__F2
redirect_from: /figures/PMC3684083__F2
figtype: Figure
---
